University of Manchester researchers have successfully carried out the first rewire of genetic switches, creating what could be a vital tool for the development of new drugs and even future gene therapies.

They rewired the genetic switches of bacteria so they are activated by a synthetic molecule instead of naturally occurring molecules found in cells.